Basic Attention Token vs Mira — how do they compare? Basic Attention Token trades at Rp1,016 (market cap Rp1,52T, Rp103,36M 24h volume), while Mira trades at Rp698.2 (market cap Rp224,51M, Rp102,44M 24h volume). The key difference: Basic Attention Token is far larger — about 6770.3× Mira's market cap, and Basic Attention Token's circulating supply is 1,5B / 1,5B BAT (100%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Basic Attention Token for 91 Days and Mira for 22 Days on average.
| BAT | MIRA | |
|---|---|---|
Market Cap | Rp1,52T | Rp224,51M |
Volume (24h) | Rp103,36M | Rp102,44M |
Circulating Supply | 1,5B / 1,5B BAT (100%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 91 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
Basic Attention Token (BAT) trades at Rp1,014 with a market cap of Rp1.51T, showing bearish technical signals overall despite some bullish oscillators. The token is trading near support at Rp1,009 with resistance at Rp1,050, while RSI levels suggest potential oversold conditions. With 100% of the 1.5M token supply in circulation and average hold time of 91 days, the token shows mature distribution.
The outlook remains cautious with strong bearish momentum indicators outweighing short-term bullish signals. Key opportunities include potential oversold bounce from support levels, while major risks involve continued bearish trend pressure and limited fundamental catalysts given the absence of recent protocol updates or ecosystem developments.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
What Pluang investors did over the last 30 days
BAT is an Ethereum-based token integrated into the privacy-focused web browser, Brave. The token is used as a payment method for running advertising campaigns through Brave Ads.
Read more on BAT →Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →